Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT04592991

CCR2 AAA Pilot Study

Targeted Molecular Probe for Abdominal Aortic Aneurysm Imaging and Therapy

Sponsor: Washington University School of Medicine

Conditions Abdominal Aortic Aneurysm (AAA)

Interventions AAA Group- PET-CT imaging with injection of 64Cu-DOTA-ECL1i Aortoiliac Occlusive Disease Group - PET-CT imaging with injection of 64Cu-DOTA-ECL1i

Updated 7 times since 2020 Last updated: Apr 9, 2022 Started: Oct 7, 2020 Primary completion: Apr 4, 2022 Completion: Apr 4, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

We were only able to enroll 1 subject so we had no way to compare a control or other study groups and develop any kind of results. This study is essentially the same study as NCT04586452, which we would like to place focus and effort on that study.

Other terminated trials from Washington University School of Medicine

See all terminations from Washington University School of Medicine

Other Abdominal Aortic Aneurysm (AAA) trials with similar outcome

NCT03231397 · Phase PHASE4 · Apr 2020

Browse all Abdominal Aortic Aneurysm (AAA) trials

This EARLY_PHASE1 trial investigates Abdominal Aortic Aneurysm (AAA) and is currently terminated or withdrawn. Washington University School of Medicine leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated EARLY_PHASE1
Sep 2024 — Sep 2025 [monthly]

Terminated EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated EARLY_PHASE1
May 2022 — Jul 2024 [monthly]

Terminated EARLY_PHASE1

Status: Recruiting → Terminated
Sep 2021 — May 2022 [monthly]

Recruiting EARLY_PHASE1

▶ Show 2 earlier versions

Jan 2021 — Sep 2021 [monthly]

Recruiting EARLY_PHASE1
Nov 2020 — Jan 2021 [monthly]

Recruiting EARLY_PHASE1

First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Washington University School of Medicine

Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• St Louis, United States